These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18275956)

  • 1. Comparison of the opioid receptor antagonist properties of naltrexone and 6 beta-naltrexol in morphine-naïve and morphine-dependent mice.
    Divin MF; Holden Ko MC; Traynor JR
    Eur J Pharmacol; 2008 Mar; 583(1):48-55. PubMed ID: 18275956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the guanine nucleotide binding protein, Gα
    Lamberts JT; Rosenthal LD; Jutkiewicz EM; Traynor JR
    Psychopharmacology (Berl); 2018 Jan; 235(1):71-82. PubMed ID: 28971229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.
    Walker EA; Sterious SN
    Br J Pharmacol; 2005 Aug; 145(7):975-83. PubMed ID: 15912139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biased Opioid Antagonists as Modulators of Opioid Dependence: Opportunities to Improve Pain Therapy and Opioid Use Management.
    Sadee W; Oberdick J; Wang Z
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32932935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of inhaled low-concentration xenon gas on naltrexone-precipitated withdrawal symptoms in morphine-dependent mice.
    Kaufman MJ; Meloni EG; Qrareya AN; Paronis CA; Bogin V
    Drug Alcohol Depend; 2024 Feb; 255():110967. PubMed ID: 38150894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series.
    Daniels DJ; Lenard NR; Etienne CL; Law PY; Roerig SC; Portoghese PS
    Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19208-13. PubMed ID: 16365317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Assessment of the Analgesic Pharmacology of NKTR-181 in Rodents.
    Kopruszinski CM; Swiokla J; Lee YS; Navratilova E; VanderVeen L; Yang M; Liu Y; Miyazaki T; Schmidt WK; Zalevsky J; Porreca F
    Cell Mol Neurobiol; 2021 Jul; 41(5):949-960. PubMed ID: 32107752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal.
    Wilson LL; Chakraborty S; Eans SO; Cirino TJ; Stacy HM; Simons CA; Uprety R; Majumdar S; McLaughlin JP
    Cell Mol Neurobiol; 2021 Jul; 41(5):1131-1143. PubMed ID: 33433723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-naphthoyl-beta-naltrexamine (NNTA), a highly selective and potent activator of μ/kappa-opioid heteromers.
    Yekkirala AS; Lunzer MM; McCurdy CR; Powers MD; Kalyuzhny AE; Roerig SC; Portoghese PS
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):5098-103. PubMed ID: 21385944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAG mu opioid receptor activation underlies sex differences in morphine antinociception.
    Bernal SA; Morgan MM; Craft RM
    Behav Brain Res; 2007 Feb; 177(1):126-33. PubMed ID: 17118467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Receptor Theory to the Design and Use of Fixed-Proportion Mu-Opioid Agonist and Antagonist Mixtures in Rhesus Monkeys.
    Cornelissen JC; Obeng S; Rice KC; Zhang Y; Negus SS; Banks ML
    J Pharmacol Exp Ther; 2018 Apr; 365(1):37-47. PubMed ID: 29330156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Chronic Naltrexone on Reinstatement of Opioid-Induced Drug-Seeking Behavior and Antinociception.
    Withey SL; Bergman J; Paronis CA
    J Pharmacol Exp Ther; 2024 Mar; 389(1):5-14. PubMed ID: 37699710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan analogues as opioid receptor ligands.
    Yuan Y; Zaidi SA; Stevens DL; Scoggins KL; Mosier PD; Kellogg GE; Dewey WL; Selley DE; Zhang Y
    Bioorg Med Chem; 2015 Apr; 23(8):1701-15. PubMed ID: 25783191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade.
    Walsh SL; Chausmer AE; Strain EC; Bigelow GE
    Psychopharmacology (Berl); 2008 Jan; 196(1):143-55. PubMed ID: 17909753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Function of (+)-Naltrexone Precursors: Their Activity as TLR4 Antagonists and Potential in Treating Morphine Addiction.
    Gao J; Lin C; Zhang C; Zhang X; Wang Y; Xu H; Zhang T; Li H; Wang H; Wang X
    J Med Chem; 2024 Feb; 67(4):3127-3143. PubMed ID: 38306598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Astrocytic µ Opioid Receptors Exacerbates Aversion Associated with Morphine Withdrawal in Mice: Role of Mitochondrial Respiration.
    Murlanova K; Jouroukhin Y; Novototskaya-Vlasova K; Huseynov S; Pletnikova O; Morales MJ; Guan Y; Kamiya A; Bergles DE; Dietz DM; Pletnikov MV
    Cells; 2023 May; 12(10):. PubMed ID: 37408246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol/naltrexone interactions at the mu-opioid receptor. CLSM/FCS study in live cells.
    Vukojević V; Ming Y; D'Addario C; Rigler R; Johansson B; Terenius L
    PLoS One; 2008; 3(12):e4008. PubMed ID: 19104662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking potential metabolic sites on NAT to improve its safety profile while retaining the pharmacological profile.
    Flammia R; Huang B; Pagare PP; M St Onge C; Abebayehu A; Gillespie JC; Mendez RE; Selley DE; Dewey WL; Zhang Y
    Bioorg Chem; 2024 Jul; 148():107489. PubMed ID: 38797065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astroglial Knockout of Glucocorticoid Receptor Attenuates Morphine Withdrawal Symptoms, but Not Antinociception and Tolerance in Mice.
    Tertil M; Skupio U; Kudla L; Wiktorowska L; Przewlocki R
    Cell Mol Neurobiol; 2022 Oct; 42(7):2423-2426. PubMed ID: 33821329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. μ Opioid receptor: novel antagonists and structural modeling.
    Kaserer T; Lantero A; Schmidhammer H; Spetea M; Schuster D
    Sci Rep; 2016 Feb; 6():21548. PubMed ID: 26888328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.